"1.
"
"Abseamed can be used to reduce exposure to allogeneic blood transfusions in adult non-iron deficient patients prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications.
"
"The target haemoglobin concentration in two studies was > 13 g/ dl; in the remaining three studies it was 12 - 14 g/ dl.
"
"Abseamed should be administered intravenously in order to increase haemoglobin to not greater than 12 g/ dl (7.5 mmol/ l).
"
"OUTER CARTON AND BOTTLE LABEL
"
"Following any confirmed or suspected overdose with aripiprazole, close medical supervision and monitoring should continue until the patient recovers.
"
"Changes in the levels of some blood cells; unusual heart beat, sudden unexplained death, heart attack; allergic reaction (e. g. swelling in the mouth, tongue, face and throat, itching, rash); high blood sugar, onset or worsening of diabetes, ketoacidosis (ketones in the blood and urine) or coma, low sodium level in the blood; weight gain, weight loss, anorexia; nervousness, agitation, feeling anxious; thoughts of suicide, suicide attempt and suicide; speech disorder, seizure, combination of fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate; fainting, high blood pressure, blockage of a blood vessel by a blood clot formed elsewhere in the body; spasm of the muscles around the voice box, accidental inhalation of food with risk of pneumonia, difficulty in swallowing; inflammation of the pancreas; inflammation of the liver, yellowing of the skin and white part of eyes, reports of abnormal liver test values, abdominal and stomach discomfort, diarrhoea; skin rash and sensitivity to light, unusual hair loss or thinning, excessive sweating; stiffness or cramps, muscle pain, weakness; involuntary loss of urine, difficulty in passing urine; prolonged and/ or painful erection; difficulty controlling core body temperature or overheating, chest pain, and swelling of hands, ankles or feet.
"
"11.
"
"In clinical trials aripiprazole has not been shown to induce clinically relevant weight gain (see section 5.1).
"
"The expiry date refers to the last day of that month.
"
"Other potent inhibitors of CYP3A4, such as itraconazole and HIV protease inhibitors, may be expected to have similar effects and similar dose reductions should therefore be applied.
"
"Increasing the infusion time from 5 to 15 minutes caused a 30% decrease in zoledronic acid concentration at the end of the infusion, but had no effect on the area under the plasma concentration versus time curve.
"
"Smoking status: according to the metabolic pathway of ABILIFY no dosage adjustment is required for smokers (see section 4.5).
"
"Particular attention should be paid to sudden stabbing migraine- like headaches as a possible warning signal.
"
"However, as with other antipsychotics, patients should be cautioned about operating hazardous machines, including motor vehicles, until they are reasonably certain that aripiprazole does not affect them adversely.
"
"Patients who develop Pure Red Cell Aplasia (PRCA) following treatment with any erythropoietin should not receive Abseamed or any other erythropoietin (see section 4.4 - Pure Red Cell Aplasia).
"
"When concomitant administration of ketoconozole with ABILIFY occurs, ABILIFY dose should be reduced to approximately one-half of its prescribed dose.
"
"transferrin saturation is below 20%.
"
"300 IU/ kg 3x/ week for 4 weeks
"
"Tel: + 420 221 016 111
"
"5.
"
"Overdose of epoetin alfa may produce effects that are extensions of the pharmacological effects of the hormone.
"
"However, since cyclosporin is bound by red blood cells there is potential for an interaction.
"
"NAME OF THE MEDICINAL PRODUCT
"
"Maintenance phase:
"
"These studies have shown an consistent unexplained statistically significant excess mortality in patients who have anaemia associated with various common cancers who received recombinant human erythropoietin compared to controls.
"
"The overall completion rate was significantly higher for patients on aripiprazole (43%) than for haloperidol (30%).
"
"The injections are given in the thighs or the anterior abdominal wall.
"
"In intravenous reproductive toxicity studies, no new safety concerns were observed at maternal exposures up to 15 (rat) and 29 (rabbit) times human exposure at 30 mg.
"
"Hyperglycaemia and Diabetes Mellitus: hyperglycaemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical antipsychotic agents, including ABILIFY.
"
"Following any confirmed or suspected overdose with aripiprazole, close medical supervision and monitoring should continue until the patient recovers.
"
"In the long term 26-week maintenance phase of a placebo-controlled trial, the incidence of EPS was 18.2% for aripiprazole-treated patients and 15.7% for placebo-treated patients.
"
"4.4 Special warnings and precautions for use
"
"There is an increased risk for thromboembolic events in patients with cancer treated with recombinant human erythropoietin and a negative impact on overall survival cannot be excluded.
"
"It is not known whether aripiprazole is excreted in human milk.
"
"Uncommon side effects (greater than 1 in 1,000, less than 1 in 100 patients) Some people may feel dizzy, especially when getting up from a lying or sitting position, or may experience a fast heart rate.
"
"Vascular disorders:
"
"In CYP2D6 poor metabolisers, concomitant use of potent inhibitors of CYP3A4 may result in higher plasma concentrations of aripiprazole compared to that in CYP2D6 extensive metabolizers.
"
"Bisphosphonate, ATC code:
"
"Dose (IU/ kg given 3x / week)
"
"Tablet
"
"The total body clearance of aripiprazole is 0.7 ml/ min/ kg, which is primarily hepatic.
"
"Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered
"
"The intravenous route has to be used (please see section 4.4 - chronic renal failure patients).
"
"Medice Arzneimittel Pütter GmbH & Co KG, Kuhloweg 37, D-58638 Iserlohn, Germany
"
"Orodispersible Tablet
"
"Only to be prepared and administered by personnel appropriately trained in handling cytotoxics.
"
"BATCH NUMBER
"
"6.
"
"186 B.
"
"In clinical trials, rare cases of NMS were reported during treatment with aripiprazole.
"
"Abseamed 6000 IU/ 0.6 ml solution for injection in a pre-filled syringe
"
"Hyperkalaemia has been observed in isolated cases.
"
"Otsuka Pharmaceutical Europe Ltd.
"
"3.
"
"54 Pharmacokinetics in special patient groups
"
"Do not freeze.
"
"Important information about some of the ingredients of ABILIFY If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
"
"4.
"
"- Treatment of anaemia associated with chronic renal failure in paediatric and adult patients on
"
"Ask your doctor or pharmacist for advice before taking ABILIFY.
"
"Abseamed 2000 IU/ 1 ml solution for injection in a pre-filled syringe
"
"Batch
"
"Neutropenia is dose-dependent and a dose-limiting toxicity.
"
"In two 3-week, flexible-dose, placebo-controlled monotherapy trials involving patients with a manic or mixed episode of Bipolar I Disorder, aripiprazole demonstrated superior efficacy to placebo in
"
"Τηλ: + 30 210 6074300
"
"Uncommon side effects (greater than 1 in 1,000, less than 1 in 100 patients) Some people may have changes in blood pressure, may feel dizzy, especially when getting up from a lying or sitting position, or may experience a fast heart rate, dry mouth or fatigue.
"
"- The other ingredients are sodium dihydrogen phosphate dihydrate, disodium phosphate
"
"When weak inhibitors of CYP3A4 (e. g., diltiazem or escitalopram) or CYP2D6 are used concomitantly with ABILIFY, modest increases in aripiprazole concentrations might be expected.
"
"8.
"
"rash, photosensitivity reaction, alopecia, hyperhidrosis
"
"EXPIRY DATE
"
"In patients with chronic renal failure and clinically evident ischaemic heart disease or congestive heart failure, maintenance haemoglobin concentration should not exceed the upper limit of the target haemoglobin concentration as recommended under section 4.2.
"
"99 1.
"
"12.
"
"Lot
"
"The frequency listed below is defined using the following convention: common (> 1/ 100 ,< 1/10) and uncommon (> 1/1 ,000, < 1/100).
"
"5.
"
"56-99 years) of aripiprazole in elderly patients with psychosis associated with Alzheimer's disease, patients treated with aripiprazole were at increased risk of death compared to placebo.
"
"you have severe disorders of blood circulation of the heart (coronary heart disease), arteries of the legs or arms (peripheral arterial occlusive disease), neck vessels (vascular disease of the carotids) or the brain (cerebrovascular disease) you had a recent heart attack or stroke
"
"6.4 Special precautions for storage
"
"It may be necessary to add or increase antihypertensive treatment.
"
"These reports are based on in vitro findings from human tumour samples, but are of uncertain significance in the clinical situation.
"
"Due to insufficient safety information in humans and concerns raised by animal reproductive studies, this medicinal product should not be used in pregnancy unless the expected benefit clearly justifies the potential risk to the foetus.
"
"- if the solution has been accidentally frozen.
"
"A single-dose study in subjects with varying degrees of liver cirrhosis (Child-Pugh Classes A, B, and C) did not reveal a significant effect of hepatic impairment on the pharmacokinetics of aripiprazole and dehydro-aripiprazole, but the study included only 3 patients with Class C liver cirrhosis, which is insufficient to draw conclusions on their metabolic capacity.
"
"3/ 3
"
"DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION
"
"As an increased incidence of thrombotic vascular events (TVEs) has been observed in cancer patients receiving erythropoiesis-stimulating agents (see section 4.8), this risk should be carefully weighed against the benefit to be derived from treatment (with epoetin alfa) particularly in cancer patients with an increased risk of thrombotic vascular events, such as obesity and patients with a prior history of TVEs (e. g. deep vein thrombosis or pulmonary embolism).
"
"FURTHER INFORMATION
"
"7.
"
"NAME OF THE MEDICINAL PRODUCT
"
"Tél/ Tel: + 32 2 352 74 60
"
"EU/ 1/ 04/ 276/ 033
"
"NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION
"
"In haemodialysed patients, a bolus injection may be given during the dialysis session through a suitable venous port in the dialysis line.
"
"PHARMACOLOGICAL PROPERTIES
"
"16 ANNEX III
"
"These trials included patients with or without psychotic features and with or without a rapid-cycling course.
"
"Due to intra-patient variability, occasional individual haemoglobin values for a patient above and below the desired haemoglobin level may be observed.
"
"The treatment is divided into two stages:
"
"In several controlled studies, epoetins have not been shown to improve overall survival or decrease the risk of tumour progression in patients with anaemia associated with cancer.
"
"SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
"
"- decreased locoregional control in patients with advanced head and neck cancer receiving
"
"174 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
"
"If signs and symptoms of tardive dyskinesia appear in a patient on ABILIFY, dose reduction or discontinuation should be considered.
"
"Natural orange cream with other natural flavours
"
"There may be a moderate dose-dependent rise in the platelet count within the normal range during treatment with epoetin alfa.
"
"Abseamed should be given by the intravenous route.
"
"This medicinal product must not be administered by intravenous infusion, or mixed with other medicinal products.
"
"At each step, the increase or reduction in dose should be of 25 IU/ kg 3 times per week.
"
"In another 12-week trial, the incidence of EPS was 26.6% for patients treated with aripiprazole and 17.6% for those treated with lithium.
"
"When aripiprazole was administered concomitantly with either valproate or lithium, there was no clinically important change in valproate or lithium concentrations.
"
"Abseamed
"
"OTHER
"
"For a full list of excipients, see section 6.1.
"
"Table 1 lists adverse reactions associated with the administration of Abraxane to patients from studies in which Abraxane has been administered as a single agent at any dose in any indication (N = 789).
"
"Inadequate thinning of the blood by heparin (heparinisation) may lead to occlusion of the dialysis system.
"
"The recommended starting dose for ABILIFY is 15 mg administered on a once-a-day schedule without regard to meals as monotherapy or combination therapy (see section 5.1).
"
"- iron supplementation, e. g.
"
"4 June 2004
"
"25 PACKAGE LEAFLET:
"
"Tél/ Tel: + 32 2 352 74 60
"
"ABILIFY is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in patients who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
"
"Alternatively, epoetin alfa can be administered at an initial dose of 450 IU/ kg subcutaneously once weekly.
"
"If you are concerned that you are given more ABILIFY solution for injection than you feel necessary, tell your doctor or nurse of your concern.
"
"4.
"
"Tel.: + 48 22 5796666
"
"Abseamed can be injected under the skin by the patient or their carer if they
"
"Tumour growth potential
"
"Correction phase:
"
"Ask your pharmacist how to dispose of medicines no longer required.
"
"Starting dose of 50 IU/ kg 3 times per week by the intravenous route, followed if necessary by a dose increase with 25 IU/ kg increments (3 times per week) until the desired goal is achieved (this should be done in steps of at least four weeks).
"
"Otsuka Pharmaceutical Europe Ltd.
"
"In two large, open-label studies, 2697 cancer patients receiving non-platinum chemotherapy were included, 1895 with solid tumours (683 breast, 260 lung, 174 gynaecological, 300 gastro-intestinal, and 478 other tumour types) and 802 with haematological malignancies.
"
"14.
"
"In another 12-week trial, the incidence of EPS was 26.6% for patients treated with aripiprazole and 17.6% for those treated with lithium.
"
"Maternal toxicity occurred at doses similar to those eliciting developmental toxicity.
"
"10000 IU/ 1.0 ml
"
"There is no experience of acute intoxication with Aclasta.
"
"Excipients
"
"If you have any further questions on the use of this product, ask your doctor or pharmacist.
"
"However, in one of these trials, a fixed-dose trial, there was a significant dose response relationship for cerebrovascular adverse events in patients treated with aripiprazole.
"
"Stability of reconstituted suspension in the vial:
"
"Skin and subcutaneous tissue disorders:
"
"5.
"
"EXPIRY DATE
"
"Patients should be advised not to breast feed if they are taking aripiprazole.
"
"rhabdomyolysis, myalgia, stiffness
"
"84 years; range:
"
"In clinical studies, 10-30 mg/ day doses of aripiprazole had no significant effect on the metabolism of substrates of CYP2D6 (dextromethorphan/ 3-methoxymorphinan ratio), 2C9 (warfarin), 2C19 (omeprazole), and 3A4 (dextromethorphan).
"
"48 The recommended dose is 600 IU/ kg epoetin alfa, given weekly for three weeks (days 21, 14 and 7) prior to surgery and on the day of surgery (day 0).
"
"5.1 Pharmacodynamic properties
"
"146 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
"
"EU/ 1/ 05/ 308/ 001
"
"Following subcutaneous injection, serum levels of epoetin alfa are much lower than the levels achieved following intravenous injection, the levels increase slowly and reach a peak between 12 and
"
"EXP IRY DATE
"
"In three short-term (4 to 6 weeks) placebo-controlled trials involving 1,228 schizophrenic patients, presenting with positive or negative symptoms, aripiprazole was associated with statistically significantly greater improvements in psychotic symptoms compared to placebo.
"
"Weight gain: weight gain is commonly seen in schizophrenic and bipolar mania patients due to co- morbidities, use of antipsychotics known to cause weight gain, poorly managed life-style, and might lead to severe complications.
"
"They may also have episodes of depression.
"
"Aripiprazole should be used with caution in patients with known cardiovascular disease (history of myocardial infarction or ischaemic heart disease, heart failure, or conduction abnormalities), cerebrovascular disease, conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications) or hypertension, including accelerated or malignant.
"
"Abraxis BioScience Limited West Forest Gate Wellington Road Wokingham Berkshire RG40 2AQ United Kingdom
"
"Subcutaneous or intravenous use
"
"Endocrine disorders:
"
"EU/ 1/ 04/ 276/ 003
"
"Two other smaller, randomised, placebo-controlled trials failed to show a significant improvement in quality of life parameters on the EORTC-QLQ-C30 scale or CLAS, respectively.
"
"149 Store in the original package in order to protect from moisture.
"
"12 g/ dl)
"
"4.6 Pregnancy and lactation
"
"Activated charcoal (50 g), administered one hour after aripiprazole, decreased aripiprazole Cmax by about 41% and AUC by about 51%, suggesting that charcoal may be effective in the treatment of overdose.
"
"Medicinal product subject to medical prescription.
"
"1 bottle - 100 ml Component of a multi-pack comprising 5 bottles, each bottle of 100 ml.
"
"Tel: + 420 221 016 111
"
"It does not matter whether you take it with or without food.
"
"Two other smaller, randomised, placebo-controlled trials failed to show a significant improvement in quality of life parameters on the EORTC-QLQ-C30 scale or CLAS, respectively.
"
"Epoetin alfa therapy should continue until one month after the end of chemotherapy.
"
"DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION
"
"Keep out of the reach and sight of children.
"
"Therefore, caution should be exercised when administering paclitaxel concomitantly with medicines known to inhibit (e. g. erythromycin, fluoxetine, imidazole antifungals) or induce (e. g. rifampicin, carbamazepine, phenytoin, efavirenz, nevirapine) either CYP2C8 or CYP3A4.
"
"MARKETING AUTHORISATION HOLDER
"
"50 IU/ kg 3 times per week by the intravenous route.
"
"Specific drug-drug interaction studies have not been conducted with zoledronic acid.
"
"Medice
"
"101 Further information on clinical trials:
"
"10 mg
"
"However, the maximum daily dose of 30 mg should be used with caution in patients with severe hepatic impairment (see section 5.2).
"
"EU Number
"
"Correction for anaemia may lead to increased appetite, and potassium and protein intake.
"
"In controlled clinical studies, use of Epoetin alfa and other erythropoiesis-stimulating agents (ESAs) have shown:
"
"Administer the amount required.
"
"Epoetin alfa did not show any changes in bacterial and mammalian cell culture mutagenicity tests and an in vivo micronucleus test in mice.
"
"1/ 1
"
"1.
"
"bottle (PET)
"
"6.5 Nature and contents of container
"
"In patients with chronic renal failure, maintenance haemoglobin concentration should not exceed the upper limit of the target haemoglobin concentration recommended in section 4.2.
"
"Lot
"
"Results of an epidemiological study found that there was no increased risk of suicidality with aripiprazole compared to other antipsychotics among patients with bipolar disorder.
"
"Studies in animals have shown reproduction toxicity (see section 5.3).
"
"No evidence exists that indicates an interaction between epoetin alfa and G-CSF or GM-CSF with regard to haematological differentiation or proliferation of tumour biopsy specimens in vitro.
"
"Treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e. g. cardiovascular status, pre-existing anaemia at the start of chemotherapy).
"
"Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
"
"- Do not freeze.
"
"The recommended starting dose for ABILIFY is 10 or 15 mg/ day with a maintenance dose of 15 mg/ day administered on a once-a-day schedule without regard to meals.
"
"1 vial
"
"Reproductive system and breast disorders:
"
"Therefore, aripiprazole should be used with caution in patients who have a history of seizure disorder or have conditions associated with seizures.
"
"For a full list of excipients, see section 6.1.
"
"Batch
"
"ABILIFY is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.
"
"12.
"
"The powder is white to yellow.
"
"Aripiprazole exhibited antagonist properties in animal models of dopaminergic hyperactivity and agonist properties in animal models of dopaminergic hypoactivity.
"
"MARKETING AUTHORISATION NUMBER(S)
"
"5.
"
"In order to ensure optimum response to epoetin alfa, adequate iron stores should be assured:
"
"6.6 Special precautions for disposal and other handling
"
"May be harmful for people with phenylketonuria.
"
"Try to take the ABILIFY tablet at the same time each day.
"
"The physician educational material should contain the following key elements: • The Summary of Product Characteristics • Reminder card with the following key messages: o Need to measure serum creatinine before treatment with Aclasta o Recommendation not to use Aclasta in patients with creatinine clearance < 35 ml/ min o Contraindication in pregnancy and in breast-feeding women due to potential teratogenicity o Need to ensure appropriate hydration of the patient o Need to infuse Aclasta slowly over a period of no less than 15 minutes o One-yearly dosing regime o Adequate calcium and vitamin D intake are recommended in association with Aclasta administration o Need for appropriate physical activity, non-smoking and healthy diet • Patient information pack
"
"Renal Disease:
"
"Meta-analysis of overall survival data produced a hazard ratio point estimate of 1.08 in favour of controls (95% CI:
"
"Haemoglobin variability should be addressed through dose management, with consideration for the haemoglobin target range of 10 g/ dl (6.2 mmol/ l) to 12 g/ dl (7.5 mmol/ l).
"
"Taking ABILIFY with some medicines may need to change your dose of ABILIFY.
"
"In addition, special precaution should be taken in patients with predisposition for development of deep vein thrombosis (DVTs).
"
"When concomitant administration of potent CYP3A4 inducers with aripiprazole occurs, the aripiprazole dose should be increased.
"
"129 Correction phase:
"
"Invented name
"
"Also contains: lactose monohydrate.
"
"What ABILIFY looks like and contents of the pack ABILIFY 30 mg orodispersible tablets are round and pink, marked with ""A"" over ""643"" on one side and 30 on the other.
"
"Dose adjustment in order to maintain haemoglobin values at the desired level:
"
"1.
"
"agitation, nervousness; suicide attempt, suicidal ideation, and completed suicide (see section 4.4)
"
"If a patient develops signs and symptoms indicative of NMS, or presents with unexplained high fever without additional clinical manifestations of NMS, all antipsychotic medicinal products, including ABILIFY, must be discontinued.
"
"pre-filled syringe (glass)
"
"Medice Arzneimittel Pütter GmbH & Co KG, Kuhloweg 37, D-58638 Iserlohn, Germany
"
"ABILIFY dose should be reduced to approximately one-half of its prescribed dose when concomitant administration of ABILIFY with quinidine occurs.
"
"ABILIFY
"
"Studies in animals have shown reproductive toxicity (see section 5.3).
"
"Potential for other medicinal products to affect ABILIFY:
"
"Although there is no information on the effect of haemodialysis in treating an overdose with aripiprazole, haemodialysis is unlikely to be useful in overdose management since aripiprazole is highly bound to plasma proteins.
"
"When concomitant administration of ketoconozole with ABILIFY occurs, ABILIFY dose should be reduced to approximately one-half of its prescribed dose.
"
"Aripiprazole is widely distributed throughout the body with an apparent volume of distribution of 4.9 l/ kg, indicating extensive extravascular distribution.
"
"Subcutaneous injection: a maximum volume of 1 ml at one injection site should generally not be exceeded.
"
"Patients should be monitored closely to ensure that the lowest approved dose of Epoetin alfa is used to provide adequate control of the symptoms of anaemia.
"
"1.
"
"5.
"
"OTHER SPECIAL WARNING(S), IF NECESSARY
"
"Due to insufficient safety information in humans and concerns raised by animal reproductive studies, this medicinal product should not be used in pregnancy unless the expected benefit clearly justifies the potential risk to the foetus.
"
"Hypersensitivity to the active substance or to any of the excipients.
"
"EU/ 1/ 07/ 412/ 013 EU/ 1/ 07/ 412/ 014
"
"OTHER
"
"Aripiprazole is widely distributed throughout the body with an apparent volume of distribution of 4.9 l/ kg, indicating extensive extravascular distribution.
"
"The protein fraction of the molecule contributes about 58% and consists of 165 amino acids.
"
"These changes are interpreted as being secondary to decreased maternal body weight gain.
"
"Č eská republika BRISTOL-MYERS SQUIBB SPOL.
"
"BATCH NUMBER
"
"Read all of this leaflet carefully before you are given this medicine.
"
"Haemoglobin variability should be addressed through dose management, with consideration for the haemoglobin target range of 10 g/ dl (6.2 mmol/ l) to 12 g/ dl (7.5 mmol/ l).
"
"Good blood management practices should always be used in the perisurgical setting
"
"200 mg oral elemental iron daily) throughout the course of treatment.
"
"However, since cyclosporin is bound by red blood cells there is potential for an interaction.
"
"Non-clinical safety data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeat-dose toxicity, genotoxicity, carcinogenic potential, and toxicity to reproduction.
"
"48 Dysphagia: oesophageal dysmotility and aspiration have been associated with antipsychotic drug use, including ABILIFY.
"
"These measures will help to protect the environment.
"
"Your doctor will weight this risk carefully against the benefits to be derived from treatment with epoetin alfa.
"
"It may harm them, even if their symptoms are the same as yours.
"
"Correction phase:
"
"INSTRUCTIONS ON USE
"
"Gender:
"
"Keep out of the reach and sight of children.
"
"100 mg
"
"STATEMENT OF ACTIVE SUBSTANCE(S)
"
"A calibrated measuring cup and a 2 ml calibrated dropper are included in the carton.
"
"You may need to read it again.
"
"Very common (≥ 1/ 10), common (≥ 1/ 100, < 1/ 10), uncommon (≥ 1/ 1,000, < 1/ 100), rare (≥ 1/ 10,000, < 1/ 1,000) adverse drug reactions are shown in Table 1.
"
"temperature regulation disorder (e. g. hypothermia, pyrexia), chest pain, peripheral oedema
"
"106 A MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
"
"11 Reconstitution and administration of the product:
"
"Haemoglobin variability should be addressed through dose management with consideration for the haemoglobin target range of 10 g/ dl (6.2 mmol/ l) to 12 g/ dl (7.5 mmol/ l).
"
"In particular, no residues of the cell line used for the production are detectable at the concentrations of the active ingredient that are used in humans.
"
"Patients should have their serum creatinine level measured before receiving Aclasta.
"
"7.7
"
"1 bottle
"
"Maintenance phase:
"
"2 maximum daily dose of 30 mg should be used with caution in patients with severe hepatic impairment (see section 5.2).
"
"Abseamed can be used to increase the yield of autologous blood from patients in a predonation programme.
"
"Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/
"
"Epoetin alfa did not show any changes in bacterial and mammalian cell culture mutagenicity tests and an in vivo micronucleus test in mice.
"
"Metabolism and nutrition disorders:
"
"France BRISTOL-MYERS SQUIBB SARL Tél: + 33 (0)810 410 500
"
"ABILIFY 7.5 mg/ ml Solution for Injection aripiprazole
"
"Abilify
"
"METHOD AND ROUTE(S) OF ADMINISTRATION
"
"In cancer patients receiving chemotherapy, the 2 - 3 week delay between epoetin alfa administration and the appearance of erythropoietin-induced red cells should be taken into account when assessing if epoetin alfa therapy is appropriate (patient at risk of being transfused).
"
"Read the package leaflet before use.
"
"In addition, other causes of anaemia, such as vitamin B12 or folate deficiency, should be excluded before instituting therapy with epoetin alfa.
"
"However, you should not dilute with other liquids or mix with other food prior to taking ABILIFY oral solution.
"
"If the rate of increase in haemoglobin exceeds 2 g/ dl (1.25 mmol/ l) per month or the haemoglobin level exceeds 13 g/ dl (8.1 mmol/ l)m, the dose adaptation detailed in section 4.2 should be thoroughly performed to minimise the risk for thrombotic events (see section 4.2 Treatment of patients with chemotherapy induced anaemia - Dosage adjustment to maintain haemoglobin concentration between 10 g/ dl - 12 g/ dl).
"
"In controlled clinical studies, use of Epoetin alfa and other erythropoiesis-stimulating agents (ESAs) have shown:
"
"Reticulocyte count increase ≥ 40,000/ µl or Hb increase ≥ 1 g/ dl
"
"Other infrequently reported side effects:
"
"• CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
"
"Haemoglobin variability should be addressed through dose management with consideration for the haemoglobin target range of 10 g/ dl (6.2 mmol/ l) to 12 g/ dl (7.5 mmol/ l).
"
"4.2 Posology and method of administration
"
"When the CYP3A4 or CYP2D6 inhibitor is withdrawn from the combination therapy, aripiprazole dose should then be increased (see section 4.5).
"
"Potential for other medicinal products to affect ABILIFY:
"
"The recommended dosing regimen is described in the following diagram:
"
"3.
"
"Epoetin alfa
"
"- if you have developed Pure Red Cell Aplasia (reduced or stopped production of red blood cells)
"
"All patients received adequate supplementation with vitamin D and calcium in the post-menopausal osteoporosis trial, the prevention of clinical fractures after hip fracture trial, and the Paget’ s disease trials (see also section 4.2).
"
"Maintenance phase:
"
"Consequently, haemoglobin and blood pressure should be closely monitored.
"
"B-CTx was significantly reduced by 61% below baseline levels at 12 months and was sustained at 55% below baseline levels at 36 months.
"
"This leaflet was last approved in
"
"EXPIRY DATE
"
"PHARMACOLOGICAL PROPERTIES
"
"Erythropoietin receptors may be expressed on the surface of a variety of tumour cells.
"
"Haemoglobin levels should be measured on a regular basis until a stable level is achieved and periodically thereafter.
"
"The reconstituted suspension has a pH of 6-7.5 and an osmolality of 300-360 mOsm/ kg.
"
"Reproductive system and breast disorders:
"
"Aclasta contains the same active substance found in Zometa (zoledronic acid), used for oncology indications, and a patient being treated with Zometa should not be treated with Aclasta.
"
"PHARMACOLOGICAL PROPERTIES
"
"In another long-term 26-week controlled trial, the incidence of EPS was 14.8% for aripiprazole-treated patients and 15.1% for olanzapine-treated patients.
"
"Reproductive system and breast disorders:
"
"Patients should not be retreated with subsequent cycles of Abraxane until neutrophils recover to > 1.5 x 109/ l and platelets recover to > 100 x 109/ l.
"
"Medicinal product subject to medical prescription.
"
"for 4 weeks
"
"If the haemoglobin increase is < 1 g/ dl (< 0.62 mmol/ l) and the reticulocyte count has increased < 40,000 cells/ µl above baseline, increase the dose to 300 IU/ kg 3 times per week.
"
"Alternatively, epoetin alfa can be administered at an initial dose of 450 IU/ kg subcutaneously once weekly.
"
"ABILIFY 10 mg orodispersible tablets aripiprazole
"
"Early shunt revision and thrombosis prophylaxis by administration of acetylsalicylic acid, for example, is recommended in these patients.
"
"France BRISTOL-MYERS SQUIBB SARL Tél: + 33 (0)810 410 500
"
"5.
"
"Medice
"
"7.
"
"Tél/ Tel: + 32 2 352 74 60
"
"Otsuka Pharmaceutical Europe Ltd commits to provide a PSUR at 6 monthly intervals unless otherwise decided by the CHMP.
"
"Intramuscular use
"
"3000 IU/ 0.3 ml
"
"Tel: + 39 06 50 39 61
"
"Care should be taken to ensure that at the outset of the treatment patients are not iron deficient.
"
"Pack of 1 or 6 syringes.
"
"What ABILIFY contains The active substance is aripiprazole.
"
"Treatment of adult patients scheduled for major elective orthopaedic surgery:
"
"INFORMATION FOR THE USER
"
"Reticulocyte count increase ≥ 40,000/ µl or Hb increase ≥ 1 g/ dl
"
"If haemoglobin has increased by at least 1 g/ dl (0.62 mmol/ l) or the reticulocyte count has increased ≥ 40,000 cells/ µl above baseline after 4 weeks of treatment, the dose should remain at 150 IU/ kg 3 times a week or 450 IU/ kg once weekly.
"
"You will also take iron supplements before and during Abseamed treatment to increase the effectiveness of Abseamed.
"
"Pre-filled syringes (glass type I) with plunger (Teflon-faced rubber) sealed in a blister.
"
"In two 3-week, flexible-dose, placebo-controlled monotherapy trials involving patients with a manic or mixed episode of Bipolar I Disorder, aripiprazole demonstrated superior efficacy to placebo in
"
"General
"
"4.
"
"This is especially important for the elderly and for patients receiving diuretic therapy.
"
"3.
"
"It is used to treat adults who suffer from a disease characterised by symptoms such as hearing, seeing or sensing things which are not there, suspiciousness, mistaken beliefs, incoherent speech and behaviour and emotional flatness.
"
"LABELLING
"
"Maintenance dose between 25 and 50 IU/ kg 2 times per week into 2 equal injections.
"
"3 years
"
"Erythropoietins are growth factors that primarily stimulate red blood cell production.
"
"14 For the purpose of ambulatory use, the patient may remove Abseamed from the refrigerator and store it not above 25°C for one single period of up to 3 days.
"
"Attention should be paid to sudden stabbing migraine-like headaches as a possible warning signal.
"
"Read the package leaflet before use.
"
"Pharmacotherapeutic group: antianaemic, ATC code:
"
"Subcutaneous injection: a maximum volume of 1 ml at one injection site should generally not be exceeded.
"
"Therefore, the company withdrew its application for the use of Abraxane as first-line treatment during the assessment of the medicine.
"
"Endocrine disorders:
"
"No other erythropoietic therapy should be commenced because of the risk of cross-reaction.
"
"13 ANNEX II
"
"PHARMACOLOGICAL PROPERTIES
"
"Hypertensive crisis with encephalopathy-like symptoms can occur.
"
"4 June 2004
"
"Non response to epoetin alfa therapy may have the following causes: iron, folate, or vitamin B12 deficiency; aluminium intoxication; intercurrent infections; inflammatory or traumatic episodes; occult blood loss; haemolysis, and bone marrow fibrosis of any origin.
"
"Subcutaneous injection: a maximum volume of 1 ml at one injection site should generally not be exceeded.
"
"The frequency listed below is defined using the following convention: common (> 1/ 100 ,< 1/10) and uncommon (> 1/1 ,000, < 1/100).
"
"4.
"
"Solvent-based paclitaxel (175 mg/ m2)
"
"The symptoms were usually transient, typically occurred three days after Abraxane administration and resolved within a week.
"
"Subcutaneous route
"
"Maternal toxicity occurred at doses similar to those eliciting developmental toxicity.
"
"Adult surgery patients in an autologous predonation programme:
"
"Smoking and Race:
"
"Potential for other medicinal products to affect ABILIFY:
"
"Solution for injection in a pre-filled syringe.
"
"Good blood management practices should always be used in the perisurgical setting
"
"A single-dose study in subjects with varying degrees of liver cirrhosis (Child-Pugh Classes A, B, and C) did not reveal a significant effect of hepatic impairment on the pharmacokinetics of aripiprazole and dehydro-aripiprazole, but the study included only 3 patients with Class C liver cirrhosis, which is insufficient to draw conclusions on their metabolic capacity.
"
"Nederland BRISTOL-MYERS SQUIBB BV Tel: + 31 34 857 42 22
"
"OTHER
"
"If you are given other medicines as part of your treatment, you should ask your doctor for advice on driving and using machines.
"
"All special warnings and precautions associated with autologous predonation programmes, especially routine volume replacement, should be respected.
"
"Following concomitant administration of carbamazepine, a potent inducer of CYP3A4, the geometric means of Cmax and AUC for aripiprazole were 68% and 73% lower, respectively, compared to when aripiprazole (30 mg) was administered alone.
"
"13.
"
"Undesirable effects known to be associated with antipsychotic therapy and also reported during treatment with aripiprazole include neuroleptic malignant syndrome, tardive dyskinesia, seizure, cerebrovascular adverse events and increased mortality in elderly demented patients, hyperglycaemia and diabetes mellitus (see section 4.4).
"
"Ελλάδα ΜΕΝΤΙΣΙ ΕΛΛΑΣ Τηλ: + 30(0)210 9960971
"
"EXPIRY DATE
"
"49 x 1
"
"If anti-erythropoietin, antibody-mediated PRCA is suspected, therapy with Abseamed should be discontinued immediately.
"
"In the open-label study there was no difference in overall survival between patients treated with recombinant human erythropoietin and controls.
"
"Abilify
"
"Interaction with receptors other than dopamine and serotonin subtypes may explain some of the other clinical effects of aripiprazole.
"
"Otsuka Pharmaceutical Europe Ltd.
"
"Abilify
"
"The use of epoetin alfa in patients scheduled for major elective orthopaedic surgery and not participating in an autologous blood predonation programme is contraindicated in patients with severe coronary, peripheral arterial, carotid or cerebral vascular disease, including patients with recent myocardial infarction or cerebral vascular accident.
"
"Ask your doctor or pharmacist for advice before taking any medicine.
"
"Gastrointestinal disorders:
"
"Oral use
"
"Manufacturer
"
"Pure Red Cell Aplasia (PRCA) Antibody-mediated PRCA has been very rarely reported after months to years of subcutaneous erythropoietin treatment.
"
"1 pre-filled syringe of 0.5 ml contains 1000 international units (IU) corresponding to 8.4 micrograms epoetin alfa
"
"Close supervision of high-risk patients should accompany antipsychotic therapy.
"
"191 Cancer patients or patients scheduled for major orthopaedic surgery
"
"This medicine has been prescribed for you.
"
"4.
"
"300 IU/ kg 3x/ week for 4 weeks
"
"haemodialysis and adult patients on peritoneal dialysis (See section 4.4).
"
"A sustained haemoglobin level of greater than 12 g/ dl (7.5 mmol/ l) should be avoided.
"
"13.
"
"3/ 3
"
"John's Wort) may be expected to have similar effects and similar dose increases should therefore be applied.
"
"4.
"
"Tel.: + 36 1 301 9700
"
"LABEL/ SYRINGE
"
"For subcutaneous and intravenous use.
"
"6.
"
"This regresses during the course of continued therapy.
"
"EU/ 1/ 07/ 412/ 001 EU/ 1/ 07/ 412/ 002
"
"Aripiprazole doses ranging from 0.5 to 30 mg administered once a day to healthy subjects for 2 weeks produced a dose-dependent reduction in the binding of 11C-raclopride, a D2/ D3 receptor ligand, to the caudate and putamen detected by positron emission tomography.
"
"LIST OF EXCIPIENTS
"
"INFORMATION IN BRAILLE
"
"România BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
"
"INSTRUCTIONS ON USE
"
"If you need more information about your medical condition or your treatment, read the Package Leaflet (also part of the EPAR) or contact your doctor or pharmacist.
"
"FURTHER INFORMATION
"
"4.3 Contraindications
"
"Dosage adjustment to maintain haemoglobin concentration between 10 g/ dl - 12 g/ dl:
"
"It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine.
"
"Cardiac disorders:
"
"Store in the original package in order to protect from moisture.
"
"Thus patients receiving Abraxane should be vigilantly monitored by physicians for the occurrence of cardiac events.
"
"Oral use
"
"Elderly patients:
"
"In animal studies, epoetin alfa has been shown to decrease foetal body weight, delay ossification and increase foetal mortality when given in weekly doses of approximately 20 times the recommended human weekly dose.
"
"Τηλ: + 357 22 677038
"
"Medicines should not be disposed of via wastewater or household waste.
"
"During antipsychotic treatment, improvement in the patient's clinical condition may take several days to some weeks.
"
"The Abseamed pre-filled syringe is ready for use.
"
"The maximum dose should not exceed 200 IU/ kg 3 times per week.
"
"When performing haematologic assessments during the preoperative period, if the haemoglobin level reaches 15 g/ dl, or higher, administration of epoetin alfa should be stopped and further doses should not be given.
"
"The orodispersible tablet can be taken with or without liquid.
"
"Using a sterile syringe, 20 ml of sodium chloride 9 mg/ml (0.9%) solution for infusion should be injected into a vial of Abraxane over a minimum of 1 minute.
"
"When concomitant administration of ketoconozole with ABILIFY occurs, ABILIFY dose should be reduced to approximately one-half of its prescribed dose.
"
"Abraxane
"
"European Medicines Agency
"
"Absorption:
"
"STATEMENT OF ACTIVE SUBSTANCE(S)
"
"6.3 Shelf life
"
"Nederland BRISTOL-MYERS SQUIBB BV Tel: + 31 34 857 42 22
"
"Intravenous injection: over at least one to five minutes, depending on the total dose.
"
"6.6 Special precautions for disposal and other handling
"
"No evidence exists that indicates an interaction between epoetin alfa and G-CSF or GM-CSF with regard to haematological differentiation or proliferation of tumour biopsy specimens in vitro.
"
"rhabdomyolysis, myalgia, stiffness
"
"Not applicable.
"
"In the four placebo-controlled studies the hazard ratios for overall survival ranged between 1.25 and 2.47 in favour of controls.
"
"Erythropoietin is a glycoprotein that stimulates, as a mitosis-stimulating factor and differentiating hormone, the formation of erythrocytes from precursors of the stem cell compartment.
"
"Aseptic techniques must be followed during the preparation of the infusion.
"
"78 Pharmacokinetics in special patient groups
"
"PHARMACEUTICAL PARTICULARS
"
"The recommended total weekly dose is between 75 and 300 IU/ kg given by the intravenous route.
"
"4.3 Contraindications
"
"urinary incontinence, urinary retention
"
"5.1 Pharmacodynamic properties
"
"In cancer patients receiving chemotherapy, the 2 - 3 week delay between epoetin alfa administration and the appearance of erythropoietin-induced red cells should be taken into account when assessing if epoetin alfa therapy is appropriate (patient at risk of being transfused).
"
"Abraxane 5 mg/ml powder for suspension for infusion Paclitaxel
"
"5.
"
"These included: dose-dependent adrenocortical toxicity (lipofuscin pigment accumulation and/ or parenchymal cell loss) in rats after 104 weeks at 20 to 60 mg/ kg/ day (3 to 10 times the mean steady-state AUC at the maximum recommended human dose) and increased adrenocortical carcinomas and combined adrenocortical adenomas/ carcinomas in female rats at 60 mg/ kg/ day (10 times the mean steady-state AUC at the maximum recommended human dose).
"
"This difference was not statistically significant.
"
"82.4 years; range:
"
"148 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
"
"The studies either recruited patients who were being treated with chemotherapy (two studies) or used patient populations in which erythropoiesis stimulating agents are not indicated: anaemia in patients with cancer not receiving chemotherapy, and head and neck cancer patients receiving radiotherapy.
"
"Oral solution
"
"Epoetin alfa
"
"Renal Disease:
"
"Solution for injection in a pre-filled syringe
"
"Another study compared Abilify with haloperidol over 12 weeks in 347 patients, and a further study compared the effectiveness of Abilify and placebo in preventing recurrence in 160 patients whose manic symptoms had already been stabilised using Abilify.
"
"6.5 Nature and contents of container
"
"POSSIBLE SIDE EFFECTS
"
"In controlled clinical studies, use of Epoetin alfa and other erythropoiesis-stimulating agents (ESAs) have shown:
"
"Alternatively, disperse the tablet in water and drink the resulting suspension.
"
"If the haemoglobin increase is < 1 g/ dl (< 0.62 mmol/ l) and the reticulocyte count has increased < 40,000 cells/ µl above baseline, increase the dose to 300 IU/ kg 3 times per week.
"
"bottle (PET)
"
"Which measures are being taken to ensure the safe use of Abseamed?
"
"7.
"
"In clinical trials and post-marketing experience, accidental or intentional acute overdosage of aripiprazole alone was identified in adult patients with reported estimated doses up to 1,260 mg with no fatalities.
"
"Vascular disorders:
"
"Comparisons between aripiprazole and placebo in the proportions of patients experiencing potentially clinically significant changes in routine laboratory parameters revealed no medically important differences.
"
"The overall completion rate was significantly higher for patients on aripiprazole (43%) than for haloperidol (30%).
"
"6.5 Nature and contents of container
"
"Abseamed is a sterile but unpreserved product and is for single use only.
"
"The pharmacokinetic characteristics of aripiprazole and dehydro-aripiprazole were found to be similar in patients with severe renal disease compared to young healthy subjects.
"
